The perigraft compartment is the dominant cellular source for decellularized tissue-engineered vascular graft recellularization
Source abstract
Abstract
Compared with conventional synthetic grafts, decellularized tissue-engineered vascular grafts (dTEVGs) hold transformative potential for hemodialysis access owing to their capacity for host‑driven recellularization. To investigate the cellular origin of this process, we established a rat arteriovenous graft model using dTEVGs and systematically mapped the temporal dynamics of infiltrating cell phenotypes. To spatially resolve cellular origins, we developed a specifically designed strategy featuring surface-specific cytophobic barriers that selectively block cellular entry from defined compartments. Our results demonstrated that abluminal blockade reduced cellular infiltration by 96.7 % and abolished collagen deposition, whereas luminal blockade showed no significant effect, definitively establishing the perigraft compartment as the dominant cellular source for dTEVG recellularization. Crucially, perigraft‑sourced cells exhibited superior proliferative capacity, stemness, and pro‑regenerative potential, making them uniquely suited for driving functional vascular regeneration. These findings, enabled by a compartment-selective blockade model, definitively establish the perigraft compartment as the dominant cellular source for recellularization in this dTEVG and underscore the critical importance of perivascular niche engagement. This work provides a methodological framework and a theoretical rationale for considering abluminal-focused strategies in the design of next-generation dTEVGs. STATEMENT OF SIGNIFICANCE: This study definitively establishes the perigraft compartment, not the lumen, as the dominant cellular source for recellularizing decellularized tissue-engineered vascular grafts. These perigraft-derived cells exhibit superior regenerative potential, overturning the long-held circulation-centric paradigm and guiding the design of next-generation grafts for improved hemodialysis access.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Infectious Aortic and Vascular Conditions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. National kidney foundation, KDOQI clinical practice guideline for vascular access: 2019 update10.1053/j.ajkd.2019.12.001 ↗
2. CONVINCE scientific committee, HDF pooling project investigators, haemodiafiltration versus haemodialysis for kidney failure: an individual patient data meta-analysis of randomised controlled trials10.1016/S0140-6736(24)01859-2 ↗
3. Reducing the burden of chronic kidney disease in the world10.1016/S0140-6736(25)00548-3 ↗
4. Challenges and novel therapies for vascular access in haemodialysis10.1038/s41581-020-0333-2 ↗
5. Causes of hemodialysis access failure10.1016/S1073-4449(12)80042-2 ↗
6. Vascular access for hemodialysis: pathologic features of surgically excised ePTFE grafts10.1007/BF02000823 ↗
7. The tissue-engineered vascular graft—past, present, and future10.1089/ten.teb.2015.0100 ↗
8. Readily available tissue-engineered vascular grafts10.1126/scitranslmed.3001426 ↗
9. Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection10.1016/j.jss.2017.08.035 ↗
10. Mechanically reinforced biotubes for arterial replacement and arteriovenous grafting inspired by architectural engineering10.1126/sciadv.abl3888 ↗
11. Translational tissue-engineered vascular grafts: from bench to bedside10.1016/j.biomaterials.2023.122322 ↗
12. Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation10.1126/scitranslmed.aau6934 ↗
13. A completely biological “off-the-shelf” arteriovenous graft that recellularizes in baboons10.1126/scitranslmed.aan4209 ↗
14. Adaptation process of decellularized vascular grafts as hemodialysis access in vivo10.1093/rb/rbae029 ↗
15. Improved porosity promotes reendothelialization and smooth muscle remodeling in decellularized tissue-engineered vascular grafts
16. Quercetin-loaded nanoparticle-modified decellularized tissue-engineered vascular graft regulates macrophage polarization and promotes In vivo graft remodeling10.2147/IJN.S505674 ↗
17. Prosthetic vascular grafts: wrong models, wrong questions and no healing10.1016/j.biomaterials.2007.07.017 ↗
18. Isolation of circulating endothelial cells provides tool to determine endothelial cell senescence in blood samples10.1038/s41598-024-54455-5 ↗
19. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration10.1161/hc0602.103673 ↗
20. Nanomedicine-based strategies for the treatment of vein graft disease10.1038/s41569-024-01094-y ↗
21. Effect of surface coatings on endothelialization and biofilm in PTFE vascular grafts10.1177/03913988251316438 ↗
22. The effect of thick fibers and large pores of electrospun poly(ε-caprolactone) vascular grafts on macrophage polarization and arterial regeneration10.1016/j.biomaterials.2014.03.078 ↗
23. Engineered cell homing10.1182/blood-2010-10-311464 ↗
24. CCR2 cooperativity promotes hematopoietic stem cell homing to the bone marrow10.1126/sciadv.adq1476 ↗
25. Arteriolar niches maintain haematopoietic stem cell quiescence10.1038/nature12612 ↗
26. Neotuberostemonine and tuberostemonine ameliorate pulmonary fibrosis through suppressing TGF-β and SDF-1 secreted by macrophages and fibroblasts via the PI3K-dependent AKT and ERK pathways
27. A bioactive compliant vascular graft modulates macrophage polarization and maintains patency with robust vascular remodeling
28. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds10.1016/j.biomaterials.2005.06.013 ↗
29. Macrophage activation and polarization: nomenclature and experimental guidelines10.1016/j.immuni.2014.06.008 ↗
30. A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation10.1002/eji.201141817 ↗
31. Origin and functions of tissue macrophages10.1016/j.immuni.2014.06.013 ↗
32. Macrophages in tissue repair, regeneration, and fibrosis10.1016/j.immuni.2016.02.015 ↗
33. Macrophages behave like mural cells to promote healing of ischemic muscle injury10.1038/s44161-024-00479-z ↗
34. Arterial Sca1+ vascular stem cells generate de novo smooth muscle for artery repair and regeneration10.1016/j.stem.2019.11.010 ↗
35. Anti-sca-1 antibody-functionalized vascular grafts improve vascular regeneration via selective capture of endogenous vascular stem/progenitor cells
36. Decellularized carotid artery functions as an arteriovenous graft10.1016/j.jss.2018.08.008 ↗
37. Transmural macrophage migration into an arterial bioresorbable vascular graft promotes inflammatory-mediated response and collagen deposition for vascular remodeling10.1016/j.actbio.2024.05.055 ↗
38. Vascular tissue reconstruction by monocyte subpopulations on small-diameter acellular grafts via integrin activation
39. Endothelialization of arterial vascular grafts by circulating monocytes10.1038/s41467-020-15361-2 ↗
40. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling10.1073/pnas.0911465107 ↗
41. Determinants of resident tissue macrophage identity and function10.1016/j.immuni.2020.05.014 ↗
42. Promoters to study vascular smooth muscle10.1161/ATVBAHA.119.312449 ↗
43. Reactive oxygen-forming Nox5 links vascular smooth muscle cell phenotypic switching and extracellular vesicle-mediated vascular calcification10.1161/CIRCRESAHA.119.316159 ↗
44. Smooth muscle cell phenotypic switch induced by traditional cigarette smoke condensate: a holistic overview10.3390/ijms24076431 ↗
45. A biomimetic approach utilizing pulsatile perfusion generates contractile vascular grafts10.1089/ten.tea.2022.0206 ↗
46. Role of vascular smooth muscle cell phenotypic switching and calcification in aortic aneurysm formation10.1161/ATVBAHA.119.312787 ↗
47. Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture10.1016/j.jvs.2012.02.030 ↗
48. Nitric oxide improves regeneration and prevents calcification in bio-hybrid vascular grafts via regulation of vascular stem/progenitor cells10.1016/j.celrep.2022.110981 ↗
49. Coatings in decellularized vascular scaffolds for the establishment of a functional endothelium: a scoping review of vascular graft refinement10.3389/fcvm.2021.677588 ↗
50. Klotho functionalization on vascular graft for improved patency and endothelialization10.1016/j.msec.2021.112630 ↗
51. Small-diameter vascular graft composing of core-shell structured micro-nanofibers loaded with heparin and VEGF for endothelialization and prevention of neointimal hyperplasia10.1016/j.biomaterials.2024.122507 ↗
52. Direct contact with endothelial cells drives dental pulp stem cells toward smooth muscle cells differentiation via TGF-β1 secretion10.1111/iej.13943 ↗
53. Bioengineering of vascularized porcine flaps using perfusion-recellularization10.1038/s41598-024-58095-7 ↗
54. Cellular energy supply for promoting vascular remodeling of small-diameter vascular grafts: a preliminary study of a new strategy for vascular graft development10.1039/D2BM01338J ↗
55. In vivo endothelialization of tubular vascular grafts through in situ recruitment of endothelial and endothelial progenitor cells by RGD-fused mussel adhesive proteins10.1088/1758-5090/7/1/015007 ↗